Background: It has been proposed that fibrin tissue adhesive (FTA) can act as an effective alternative to nasal packing in managing the postoperative symptoms of endoscopic nasal surgery.
Introduction Rationale
Nasal packing is often used as a method of controlling postoperative bleeding in various types of endonasal surgery, including functional endoscopic sinus surgery (FESS), septoplasty and conchotomy. Conventional packing materials such as Merocel are formed of a compressed, dehydrated sponge that is inserted into the nasal cavity at the conclusion of an operation; upon rehydration with blood, they expand to three times their normal size, compressing any bleeding vessels (1, 2) . Despite their prevalence, the efficacy of these materials is often not substantiated by the evidence, with many studies reporting that endonasal procedures can be successfully managed without the use of nasal packing (3) (4) (5) . Furthermore, Merocel and other non-absorbable packs have been associated with increased pain and local infection whilst in situ, and significant pain upon removal (6) (7) (8) (9) .
Attempts to rectify the drawbacks of Merocel have led to the development of absorbable nasal packs, such as Nasopore. These materials (formed of synthetic polyurethane foam) provide the initial structural properties required for haemostasis, alongside a hydrophilic component that allows their dissolution within a number of days (10) . One could reasonably expect that absorbable packs would be associated with less pain alongside a similar haemostatic efficacy, however the evidence is conflicting. One trial noted that Nasopore was a significant factor in the formation of excessive granulation tissue and major postoperative bleeding after FESS (11) , whilst a meta-analysis comparing Nasopore against Merocel concluded that the quality of evidence is too low to make any definitive conclusions (2) . Consequently, no it adheres strongly to tissue at the surgical site achieving instant haemostasis (12, 13) . The topical application of FTA also negates the need for any postoperative removal, limiting the pain felt by patients (13) . If FTA was shown to be an effective haemostatic, it could theoretically replace the use of nasal packing and be associated with far fewer side-effects. Whilst debate surrounds the use of these materials regarding their expense, the adoption of FTA in other specialties, especially soft tissue head and neck surgery, is sufficient to warrant further investigation into its use in endoscopic nasal surgery (14) .
Objectives
To examine whether FTA is a safe and effective alternative to other methods of nasal packing in adult patients undergoing endoscopic nasal surgery. We reviewed randomised controlled trials (RCTs) that compared the use of FTA with absorbable or non-absorbable nasal packs and reported on the incidence of postoperative symptoms.
Materials and methods

Protocol and registration
This review was conducted in accordance with the PRISMA checklist (15) . The methodology of the review was determined in advance and registered on PROSPERO (16) .
Information sources
MEDLINE, Embase, The Cochrane Library, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and ClinicalTrials.gov were used to search for indexed articles to be included in this review. Searches were not limited by language or time of publication, and the last search was conducted on the 8th January 2018 (see Appendix 1-4 for full search strategy). Additional eligible studies were sought from the grey literature, the complete works of key authors and the reference lists of the included studies from the initial search.
Eligibility criteria
Only randomised controlled trials comparing the use of FTA with absorbable or non-absorbable nasal packing in adult (≥ 18 years) participants undergoing endoscopic nasal surgery (FESS, septoplasty and conchotomy) were included. The primary outcome of interest was bleeding, with secondary outcome measures including postoperative pain, nasal obstruction, adhesion rate, infection rate and the formation of granulation tissue.
This review was limited to the comparison of FTA with structural nasal packing (i.e. achieving haemostasis through compression), and so studies comparing FTA to other materials containing active haemostatic agents (such as thrombin in Floseal) were excluded (13) .
Study selection and data extraction
Study selection and data extraction were carried out according to the PRISMSA guidelines and completed independently by two reviewers (J.C and U.I); any disagreements were resolved by consensus through discussion with a third reviewer (PW) (15) .
Risk of bias in individual studies
Risk of bias was assessed independently by two authors (J.C and O.P) using the Cochrane Collaboration's tool for assessing risk of bias in randomised trials (17) . Each judgement was based on the guidance of adequate and inadequate methods of alleviating bias within each domain in the Cochrane Handbook (18) .
Statistical analysis
Cochrane Q and I 2 tests were conducted to assess the studies included in the meta-analysis for heterogeneity (19) . The meta-analysis was performed by calculating effect sizes using a randomeffects model in order to have dichotomous and categorical outcomes in the same analysis (20) . The primary outcome for analysis was bleeding. For outcomes reported dichotomously, odds ratios were calculated and transformed into effect sizes using the formula d = LnOR×(√3/π) on Microsoft Excel (20) . For outcomes reported as means and standard deviations, Cohen's d was calculated according to the formula d = (M2 -M1) ⁄ SDpooled (21) .
The effect size meta-analysis was conducted using Stats Direct statistical software version 2.8.0.
Results
Study selection
315 studies were retrieved from the search, of which six were eligible for inclusion. The PRISMA flowchart (Figure 1 ) details the number of studies at each stage of the selection process and the reasons for exclusion (15) . Unfortunately, upon initial analysis it became apparent that one study did not include a denominator in the results (22) , and a second study was noted to have a significant overlap in participants after consultation with the author (23) . These studies were subsequently removed, and the remaining four studies underwent analysis (12, (24) (25) (26) .
Study characteristics
The study characteristics are presented in 
Results of individual studies
The results of the individual studies are detailed in Table 2 .
The studies by Vaiman et al. and Gleich et al. presented data as binary outcomes (24, 26) ; the studies by Jung et al. and Yu et al. used an ordinal scale (0 = absent to 3 = severe) to grade the severity of outcomes measured by clinicians, and a VAS (0 = no symptoms to 10 = unbearable) to grade the severity of outcomes measured by participants (12, 25) . Since bleeding was assessed by both clinicians and participants in some studies, the method used is indicated in the table (12, 25) . Additionally, where studies presented clinician-assessed outcome data on a range of follow these acting as 'split-participants' , meaning they received the intervention in one nasal cavity and the comparison in the other (12, 24, 25) . All studies used FTA as the sole intervention with either Merocel (12, 26) , Nasopore (25) , or Gelfoam as the comparison (24) .
The outcomes were assessed by clinicians and/or participants.
Bleeding, adhesions, infection rate and the formation of granulation tissue were clinician-assessed, and bleeding, pain and nasal obstruction were participant-assessed.
Risk of bias within studies
There was a significant level of variance in the quality of the included studies, with a frequently high risk of performance Figure 1 . PRISMA flow diagram for the literature search (13) . RCT = randomised controlled trial, FTA = fibrin tissue adhesive, n = number of participants. Figure 2 . A summary of the Cochrane risk of bias assessment (16) . + = low risk, -= high risk, ? = unclear risk. (12, 25) .
Syntheses of results
A combination of limited reporting and/or flawed data across the studies for the secondary outcomes meant it was only appropriate to pool the results for the primary outcome of bleeding. Secondary outcomes have therefore been compared narratively.
Primary outcome
A random-effects model for meta-analysis was used following the results of the tests for heterogeneity, which showed a large difference between the included studies (I 2 = 56% (0% to 83.5%), Q = 6.82, p=0.08). Figure 3 shows the forest plot of data for the four included studies (12, (24) (25) (26) . (12, 25) , whilst one study showed no effect (Gleich et al., d = 0 ((n/a) -0.80)) (24) , and the other study favoured the control over the intervention (Vaiman et al., d = -0.62
(-1.12 --0.12)) (26) . The overall pooled effect favoured the control over the intervention (d = 0.10 (-0.33 -0.57)) but this was not statistically significant (p = 0.75). Overall this meta-analysis must be interpreted with caution due to the high heterogeneity.
Secondary outcomes
Postoperative pain was reported in two studies (12, 25) . No significant difference was reported in either study for 'pain during packing' or 'pain on dressing' between the FTA and control groups; a significant difference was however noted for 'pain on packing removal' in one study (12) . Unfortunately, much of the data presented here is flawed: pain during packing was not clarified as the process of packing or the pain felt whilst in situ, and those in the FTA group did not receive packing and were therefore not applicable for inclusion in outcomes relating to packing removal. This also explains why the p-value was accordingly small (p<0.0001) for the 'pain on packing removal' outcome (12) . Therefore, pooling of the results was not justified, and there is insufficient evidence to suggest that perceived pain is lower in Figure 3 . Forest plot for the primary outcome of bleeding (6, 7, 22, 25) . Nasal obstruction was reported by three studies (12, 24, 25) . (12, 25) . Gleich et al. also reported a difference, however, this was a narrative description stating that all patient felt the FTA side felt more patent than the control side, with no provision of any raw data or statistical analysis to support this (24) . (12, 25) . In addition, there was also no significant difference noted for any other reported follow up time (12, 25) . (12, 25) . In addition, there was also no significant difference noted between the groups for any other reported follow up time (12, 25) .
Author
The formation of granulation tissue was reported only by Jung et al., who noted that granulation was significantly lower in the FTA group compared to the control at postoperative week four (p < 0.05 (0.41 ± 0.40 and 1.24 ± 0.61)) (25) . No other reported follow up times noted a statistically significant difference between the groups (25) .
Discussion
Quality of evidence
The limitations of the included studies are important in understanding the applicability of these results. Although bleeding was a reported outcome in all studies, the small sample size coupled with a substantial risk of bias mean these results must be interpreted with caution. This is further enhanced by the exclusion of two eligible studies for poor outcome reporting and a 30% overlap in patients; this not only resulted in the loss of 698 participants from the analysis, but also the only data reporting on outcomes in septoplasty and conchotomy. Consequently, our findings are only applicable to FESS, and there was significant heterogeneity in the methodology of the remaining studies.
Unfortunately, the presence of only four eligible studies meant our original intention of performing a subgroup analysis for different packing materials was inappropriate. As a result, both absorbable and non-absorbable packing materials were grouped together, and the conclusions reached in this review cannot be used to differentiate between these materials.
Comparison with other research
A previous systematic review comparing all biodegradable materials to conventional nasal packing echoed the results of this review (13) . They too found no difference between the groups in postoperative bleeding rates and significantly less nasal obstruction in the biodegradable packing group (13) . Similarly, Yan et al. were unable to draw conclusions on individual materials (notably FTA) as a consequence of collating the results of all biodegradable haemostatics into one group (13) .
With advancing and meticulous surgical technique, immediate postoperative bleeding may be controlled without the need for nasal packing at all. Some studies have shown no difference in bleeding, adhesions, infection and nasal obstruction between using and omitting packing (both absorbable and non-absorbable) altogether in endonasal surgery (9, 27) . Unfortunately, as has become a common theme, the existence of studies demonstrating evidence to the contrary (i.e. significant bleeding when packing is not used) confirms that decisions taken by clinicians continue to be based on personal preference (28) .
Implications for clinical practice and further research
It is clear from the presented data that the current evidencebase is not yet robust enough to recommend the use of FTA in replacement of nasal packing. The lack of any cost-benefit analyses in the included studies also enhances concerns surrounding the expense of biodegradable haemostatics. Currently, the list price for 10ml of Artiss (a commonly used FTA) is $880.68
(around £680) (29) ; this highlights the cost-effectiveness of Merocel, which can be bought for just £2.61 per pack (30) . Whilst savings made through shorter operation times or reduced follow-up visits might bring the cost of FTA more in line with that of nasal packing, commenting on this before a comprehensive cost-benefit analysis is performed would be inappropriate.
Despite these uninspiring results, they do serve to emphasise the lack of any comprehensive research in this area. Only when a multi-centre RCT compares the use of FTA with all forms of packing will clinicians be able to make a more informed choice about the material they recommend for their patients.
Conclusion
With Whilst an interesting development, the current research is conducted on a small sample size and shows significant heterogeneity and performance bias. As such, drawing any meaningful conclusions is limited. Our results therefore serve to highlight the lack of research in this area, and should not be used to guide practice until clinical trials with more robust methodology are conducted.
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Appendix 2. Search Strategy for Embase (Ovid host).
Search Term Thesaurus Term
Subheading / Search Field 
Bias Author's Judgement of Risk
Support for Judgement
Random sequence generation (selection bias)
High risk Quote: "The side of application of fibrin tissue adhesive was randomly assigned before surgery… When the patient's symptoms were more severe on one side or when, during the procedure, one side was noted to have more severe disease, that side was selected for application of fibrin" (24) . Comment: The study does not clarify this, or state which method of randomisation was used, however they do state that disease severity influenced how they organised patients into each group, which is a poor way to conduct a randomised controlled trial. Allocation concealment (selection bias)
High risk
Although there was no information on the method of randomisation, the knowledge of the researchers that they could allocate patients to a particular group based on disease severity meant the allocation sequence was not concealed.
Blinding of participants and researchers (performance bias)
High risk It was not stated if participants or researchers were kept blind to the intervention, however participants may have been able to tell if they were in the Gelfoam foam packing group due to the nasal obstruction. Furthermore, it would not have been possible to blind the surgeons as to which participants were receiving Gelfoam and which received FTA. Table for Jung et al (25) .
Bias Author's Judgement of Risk
Support for Judgement
Low risk Quote: "1 nasal cavity randomly received aerosolised FS [fibrin sealant] and the opposite received Nasopore packing material according to a computer-generated randomisation prepared by nursing staff" (25) . Allocation concealment (selection bias)
Low risk
The randomisation sequence was computer-generated and performed by nursing staff, meaning it would not be possible for the surgeon to foresee the allocation sequence.
Blinding of participants and researchers (performance bias)
High risk Quote: "The patients and observers were not informed of which side received which packing material" (25) . Comment: Although participants were kept blind to the intervention, by the nature of the foam packing, it would likely have been possible to tell which cavity had Nasopore and which had FTA. Furthermore, it would not be possible to blind the providers (surgeons) to which intervention was used in which nasal cavity.
Blinding of outcome assessment (detection bias) Participant-assessed outcomes: Unclear risk Quote: "A physician other than the operating surgeon compared the subjective severity of symptoms… postoperative endoscopic findings were assessed by outside observers using grading scales" (25) . Comment: Whilst third party independent clinicians collected the data, some outcomes were assessed by the participants themselves. Due to the reasons stated above, if patients could feel which side had the Nasopore packing, this may have influenced their assessment. The clinician-assessed outcomes, however, would not have been affected and these were assessed by a physician other than the operating surgeon.
Clinician-assessed outcomes: High risk Incomplete outcome data (attrition bias)
Quote: "43 patients were enrolled; and 35 patients underwent surgery and analysis" (25) . Comment: Despite 8 participants being enrolled but not undergoing surgery, in this study there was not an intervention and control group, but an intervention and control nasal cavity. This means every participant is acting as both the intervention and control group simultaneously; this prevents a disproportionate drop-out from one particular group. Furthermore, the eight participants were excluded before the intervention was administered, so these are not considered to have missing outcome data.
Selective reporting (reporting bias)
The trial protocol was not available via a google search. As a result, the methods section was used to compare intended outcomes with outcomes reported. The objectives for the study were to compare nasal packing against FTA use for haemostatic efficacy and wound healing. These outcomes were reported equally for both groups alongside many other complications, such as adhesion rate and pain. There is therefore no evidence of selective outcome reporting.
Other bias Unclear risk Some patients may have received more FTA than others, and this could have impacted on the clinician and participant-assessed outcomes assessed, especially of bleeding. (24) . Comment: Certain outcomes were assessed by the participants, and if they could feel which nasal cavity had Gelfoam packing, this may have influenced their assessment. Furthermore, endoscopic evaluation of outcomes was performed by the same surgeon that performed the operations rather than independent researchers. Clinician-assessed outcomes: High risk Incomplete outcome data (attrition bias)
Unclear risk
In this study there was not an intervention and control group, but an intervention and control nasal cavity. This means every participant is acting as both the intervention and control group simultaneously; this prevents a disproportionate drop-out from one particular group. However, there was no data available to explicitly say if patients had been lost to follow up.
Unclear risk The trial protocol was not available via a google search. As a result, the methods section was used to compare intended outcomes with outcomes reported. No specific objectives were set out in this study, and so it is not possible to tell if the reported outcomes matched what was initially intended to be studied -furthermore, one of the intended outcome measures was not clearly reported (comfort).
Other bias Unclear risk Some patients may have received more FTA than others, and this could have impacted on the clinician and participant-assessed outcomes assessed, especially of bleeding. Table for Yu et al. (12) . Appendix 7. Risk of Bias (26) .
Bias Author's Judgement of Risk
Support for Judgement
Unclear risk Quote: "Patients… were then randomised for further haemostatic technique by a sealed-envelope method" (26) . Comment: This randomisation method can be considered as simple randomisation, which may not be appropriate in a sample size of just 64. Furthermore, it was not stated how the envelopes were prepared or shuffled. Allocation concealment (selection bias)
Unclear risk
It was not stated who prepared or selected the envelopes, or if the envelopes were sequentially numbered and opaque. It therefore cannot be assumed that the person selecting the envelopes was unaware of the method used to generate the randomisation allocation sequence.
High risk Quote: "The patients were randomly assigned by the sealed-envelope method, double blind, to one of two treatment groups" (26) . Comment: The term 'double blind' was not qualified, and so it cannot be assumed who was subject to blinding. Furthermore, participants may have been able to tell if they were in the Merocel foam packing group due to the nasal obstruction, and it would not have been possible to blind the surgeons as to which participants were receiving Merocel and which received FTA.
Blinding of outcome assessment (detection bias) Participant-assessed outcomes: Unclear risk
Quote: "The observers were the authors and other physicians from the otolaryngology department, blind to the original intervention" (26) . Comment: Whilst third party clinicians collected the data, some outcomes were assessed by the participants themselves. Due to the reasons stated above, if participants could feel if they had the Merocel packing, this may have influenced their outcome assessment as they were not blind to the intervention. The clinician-assessed outcomes, however, would not have been affected, and these were assessed by observers who were blind to intervention.
Low risk
Quote: "No patients were lost to follow up" (26) . Comment: all patients that were enrolled and randomised completed the study.
High risk
The trial protocol was not available via a google search. As a result, the methods section was used to compare intended outcomes with outcomes reported. The aim of the study was to compare the haemostatic properties of fibrin sealant with nasal packing. Haemostatic efficacy was assessed equally between the groups, however only additional clinician-assessed outcomes (adhesions, atrophic changes) were evaluated in the FTA group and additional participant-assessed outcomes (pain, obstruction) were evaluated in the nasal pack group. This again raises the suspicion of selective reporting, as there was evidence of all participant-assessed symptoms in the nasal-packing group, and no evidence of any clinician-assessed outcomes in the FTA Other bias Unclear risk Some patients may have received more FTA than others, and this could have impacted on the clinician and participant-assessed outcomes assessed, especially of bleeding.
FTA = Fibrin tissue adhesive
Bias
Author's Judgement of Risk
Support for Judgement
Low risk Quote: "The order of packing was randomized according to a computer-generated randomization that was prepared by the nursing staff when the surgery was completed but before the packing was inserted" (12) . Comment: Computer-generated sequence generation can be considered low risk. Allocation concealment (selection bias)
Low risk
High risk It was not stated if participants or researchers were kept blind to the intervention, however participants may have been able to tell if they were in the Merocel foam packing group due to the nasal obstruction. Furthermore, it would not have been possible to blind the surgeons as to which participants were receiving Merocel and which received FTA.
It was not stated who collected the data and if they were blind to intervention. Certain outcomes were assessed by the participants themselves; due to the reasons stated above, if patients could feel if they had the Merocel packing, this may have influenced their assessment as they were not blind to the intervention. Clinician-assessed outcomes would not have been affected by this, but by not stating if the observers were blind, we cannot assume they were. Clinician-assessed outcomes: High risk 
Support for Judgement
Incomplete outcome data (attrition bias)
Low risk Quote: "50 patients were enrolled, and 41 patients underwent surgery and analysis. A total of nine patients who were enrolled did not undergo surgery and were thus excluded" (12) . Comment: Despite nine participants being enrolled but not undergoing surgery, in this study there was not an intervention and control group, but an intervention and control nasal cavity. This means every participant is acting as both the intervention and control group simultaneously; this prevents a disproportionate drop-out from one particular group. Furthermore, the nine participants were excluded before the intervention was administered, so these are not considered to have missing outcome data.
Low risk
The trial protocol was not available via a google search. As a result, the methods section was used to compare intended outcomes with outcomes reported. The objectives of this study were to "determine the effect of aerosolised [fibrin sealant] on haemostasis and wound healing after [functional endoscopic sinus surgery] compared with a standard non-absorbable packing (Merocel) requiring removal. Our secondary objective was to examine the subjective severity of symptoms after [functional endoscopic sinus surgery]" (12) . These outcomes were reported equally between the FTA and packing sides, alongside additional outcome measures. There is therefore no evidence to suggest that some outcomes were deliberately not reported.
Other bias
Unclear risk Some patients may have received more FTA than others, and this could have impacted on the clinician and participant-assessed outcomes assessed, especially of bleeding.
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